Stocks to Watch: Entanta Pharmaceuticals, JFB Construction, SOS Ltd.

Dow Jones

Sep 27, 2025

By Katherine Hamilton

Entanta Pharmaceuticals said it plans to present topline trial results for its respiratory syncytial virus treatment. The stock gained 19% to $9.38 in after-hours trading Friday.

JFB Construction entered into a private placement agreement worth $43.9 million. Shares doubled to $13.49 after the bell on Friday.

SOS Limited reported an increase in revenue and said it was allocating resources away from its crypto mining business. Shares climbed 32% to $2.58 after hours on Friday.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

- -

(END) Dow Jones Newswires

September 26, 2025 18:14 ET (22:14 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2570858242"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570858242\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570858242?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-27 06:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570858242","market":"other","top_or_hot":-1,"title":"Stocks to Watch: Entanta Pharmaceuticals, JFB Construction, SOS Ltd.","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Stocks to Watch: Entanta Pharmaceuticals, <a href=\"https://laohu8.com/S/JFB\">JFB Construction</a>, SOS Ltd. \n</p>\n<p>\n  By Katherine Hamilton \n</p>\n<p>\n  Entanta Pharmaceuticals said it plans to present topline trial results for its respiratory syncytial virus treatment. The stock gained 19% to $9.38 in after-hours trading Friday. \n</p>\n<p>\n  JFB Construction entered into a private placement agreement worth $43.9 million. Shares doubled to $13.49 after the bell on Friday. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/SOS\">SOS Limited</a> reported an increase in revenue and said it was allocating resources away from its crypto mining business. Shares climbed 32% to $2.58 after hours on Friday. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n- - \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 26, 2025 18:14 ET (22:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: Entanta Pharmaceuticals, JFB Construction, SOS Ltd.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: Entanta Pharmaceuticals, JFB Construction, SOS Ltd.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-09-27 06:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Stocks to Watch: Entanta Pharmaceuticals, <a href=\"https://laohu8.com/S/JFB\">JFB Construction</a>, SOS Ltd. \n</p>\n<p>\n  By Katherine Hamilton \n</p>\n<p>\n  Entanta Pharmaceuticals said it plans to present topline trial results for its respiratory syncytial virus treatment. The stock gained 19% to $9.38 in after-hours trading Friday. \n</p>\n<p>\n  JFB Construction entered into a private placement agreement worth $43.9 million. Shares doubled to $13.49 after the bell on Friday. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/SOS\">SOS Limited</a> reported an increase in revenue and said it was allocating resources away from its crypto mining business. Shares climbed 32% to $2.58 after hours on Friday. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n- - \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 26, 2025 18:14 ET (22:14 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4547","symbol_name":"WSB热门概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2570858242","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570858242","pubTimestamp":1758924840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Entanta Pharmaceuticals said it plans to present topline trial results for its respiratory syncytial virus treatment. The stock gained 19% to $9.38 in after-hours trading Friday.JFB Construction entered into a private placement agreement worth $43.9 million. Shares doubled to $13.49 after the bell on Friday.SOS Limited reported an increase in revenue and said it was allocating resources away from its crypto mining business. Shares climbed 32% to $2.58 after hours on Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4547":"WSB热门概念","BK4123":"调查和咨询服务","JFB":"JFB Construction Holdings","SOS":"SOS Limited","BK4129":"建筑与工程"},"translate_title":"值得关注的股票：Entanta Pharmaceuticals、JFB Construction、SOS Ltd.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JFB":1.5,"SOS":1.5},"content_text":"Stocks to Watch: Entanta Pharmaceuticals, JFB Construction, SOS Ltd. \n\n\n  By Katherine Hamilton \n\n\n  Entanta Pharmaceuticals said it plans to present topline trial results for its respiratory syncytial virus treatment. The stock gained 19% to $9.38 in after-hours trading Friday. \n\n\n  JFB Construction entered into a private placement agreement worth $43.9 million. Shares doubled to $13.49 after the bell on Friday. \n\n\nSOS Limited reported an increase in revenue and said it was allocating resources away from its crypto mining business. Shares climbed 32% to $2.58 after hours on Friday. \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n- - \n\n\n  (END) Dow Jones Newswires\n\n\n  September 26, 2025 18:14 ET (22:14 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}